GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
28 hedge funds and large institutions have $6.71M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$747K | |
| 2 | +$668K | |
| 3 | +$361K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$52.3K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$5K |
Top Sellers
| 1 | -$769K | |
| 2 | -$392K | |
| 3 | -$305K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$239K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$214K |